The Associated Banc-Corp holds 112,905 shares with $9.18M value, up from 107,922 last quarter. The stock decreased 0.30% or $0.24 during the last trading session, reaching $78.78. About 96,404 shares traded. It has underperformed by 41.10% the S&P500.
Investors sentiment decreased to 1.26 in 2017 Q3. Its down 0.04, from 0.92 in 2017Q2. It dropped, as 21 investors sold AEL shares while 65 reduced holdings. 88 funds opened positions while 466 raised stakes.
AEL has been the topic of several analyst reports. Virginia Retirement Et Al owns 82,800 shares for 0.03% of their portfolio. Rmb Mngmt Lc holds 155,092 shares. Addenda holds 0.36% in CVS Health Corporation (NYSE:CVS) or 63,703 shares. Numeric Ltd Com holds 0.27% or 427,217 shares in its portfolio. Citigroup reported 1,321 shares. Amp Capital Investors accumulated 0% or 16,700 shares. Seizert Cap Ltd Liability Corporation has 1.43% invested in CVS Health Corporation (NYSE:CVS). Boston Ptnrs has 253,700 shares for 0.01% of their portfolio. Morgan Stanley stated it has 189,209 shares. Lathrop Inv Mgmt holds 143,955 shares or 3.31% of its portfolio. D E Shaw And invested in 0% or 50,632 shares. Its up 16.43% from 7.39 million shares previously. Moreover, Aqr Limited Liability Co has 0.16% invested in CVS Health Corporation (NYSE:CVS) for 1.64M shares. Brinker Cap owns 11,398 shares. Eog Res Inc (NYSE:EOG) was reduced too. Five research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Therefore 33% are positive. CVS Health had 65 analyst reports since July 22, 2015 according to SRatingsIntel. Oppenheimer maintained the stock with "Outperform" rating in Thursday, December 17 report. Finally, Goldman Sachs Group initiated coverage on shares of American Equity Investment Life in a research note on Wednesday, October 18th. As per Tuesday, May 23, the company rating was maintained by RBC Capital Markets. The firm earned "Buy" rating on Friday, November 10 by Needham. FBR Capital maintained it with "Outperform" rating and $30.0 target in Monday, August 10 report. On Thursday, August 20 the stock rating was upgraded by TheStreet to "Hold". The firm has "Outperform" rating given on Thursday, February 11 by RBC Capital Markets. Cowen & Co maintained CVS Health Corporation (NYSE:CVS) on Tuesday, June 13 with "Buy" rating. As per Monday, December 4, the company rating was maintained by Keefe Bruyette & Woods. On Friday, April 28 the stock rating was initiated by Tigress Financial with "Buy". $1.67M worth of CVS Health Corporation (NYSE:CVS) shares were sold by Moriarty Thomas M. 2,500 shares were sold by SWIFT RICHARD J, worth $199,050.
American Equity Investment Life (NYSE:AEL) was downgraded by ValuEngine from a "strong-buy" rating to a "buy" rating in a research report issued on Friday, December 29th. They expect $-0.20 earnings per share, down 42.86% or $0.06 from last year's $-0.14 per share. AEL's profit will be $59.72M for 12.67 P/E if the $0.67 EPS becomes a reality.
American Equity Investment Life Holding Company (NYSE:AEL)'s earnings per share has been growing at a -6.7 percent rate over the past 5 year when average revenue increase was noted as 14.3 percent. The stock decreased 1.19% or $0.41 during the last trading session, reaching $33.96. About 750,112 shares traded or 10.45% up from the average. It has outperformed by 48.16% the S&P500. Deutsche Bank & Trust Ag reported 0.01% in American Equity Investment Life Holding Company (NYSE:AEL). Zurcher Kantonalbank (Zurich Cantonalbank) owns 0% invested in American Equity Investment Life Holding Company (NYSE:AEL) for 3,948 shares. AEL was included in 5 notes of analysts from October 7, 2016. JP Morgan upgraded it to "Overweight" rating and $20 target in Monday, June 6 report. On Tuesday, September 19 the stock rating was maintained by UBS with "Neutral".
The stock of American Equity Investment Life Holding Company (NYSE:AEL) hit a new 52-week high and has $37.02 target or 9.00% above today's $33.96 share price. The company has a current ratio of 0.12, a quick ratio of 0.12 and a debt-to-equity ratio of 0.27. Royal Bank of Canada increased their price target on American Equity Investment Life from $30.00 to $32.00 and gave the stock an "outperform" rating in a research note on Wednesday, November 8th.
Acuta Capital Partners Llc holds 5.18% of its portfolio in Veracyte, Inc. for 3.30 million shares. The New York-based Broadfin Capital Llc has invested 1.32% in the stock. Eventide Asset Management Llc, a Massachusetts-based fund reported 2.13 million shares.
Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.